Global Peptide Therapeutics Market Report 2022 to 2028: Players Include AstraZeneca, Teva Pharmaceutical Industries, Novartis and Pfizer
24 nov. 2022 08h03 HE | Research and Markets
Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By...
The Worldwide Monoclonal Antibodies in Veterinary Health Industry is Expected to Reach $2.6 Billion by 2030
08 nov. 2022 06h28 HE | Research and Markets
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type, By Application, By End-Use, By Region,...
$264 Worldwide Monoclonal Antibody Therapeutics Industry to 2027 - Featuring AbbVie, Amgen, Bayer and Biogen Among Others
01 nov. 2022 05h28 HE | Research and Markets
Dublin, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Therapeutics Market (2022-2027) by Source, End-Users, Applications, and Geography, Competitive Analysis and the Impact of...
Antibody Fragments Market to Reach $11.71 Billion by 2030
24 oct. 2022 05h23 HE | Research and Markets
Dublin, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The "Antibody Fragments Market Share, Size, Trends, Industry Analysis Report, By Specificity, By Type, By Therapy, By Application, By Region, Segment...
Cancer Monoclonal Antibodies Market Report 2022: Featuring AbbVie, Bristol-Myers Squibb, Eli Lilly, Pfizer, Novartis, Merck & More
19 oct. 2022 08h08 HE | Research and Markets
Dublin, Oct. 19, 2022 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Compass-logo-RGB-outlines.png
Compass Therapeutics Announces Clinical Collaboration with Merck to Evaluate CTX-471 in Combination with KEYTRUDA® (pembrolizumab)
11 oct. 2022 08h00 HE | Compass Therapeutics
BOSTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
22157.jpg
Oral Biologics & Biosimilars Global Market to Reach $9.44 Billion by 2026 at a 15.9% CAGR
03 oct. 2022 05h13 HE | Research and Markets
Dublin, Oct. 03, 2022 (GLOBE NEWSWIRE) -- The "Oral Biologics & Biosimilars Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global oral biologics &...
Global Monoclonal Antibodies (mAbs) Market Analysis Report 2022: A Projected $494.53 Billion Market by 2030
30 sept. 2022 05h58 HE | Research and Markets
Dublin, Sept. 30, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies Market Size, Share & Trends Analysis Report by Source Type (Chimeric, Murine, Humanized, Human), by Production Type (In...
22157.jpg
Global Biopharmaceutical Manufacturing Capacity and Production Report and Survey 2022: Compare 140+ Biomanufacturers vs CMOs; U.S. vs. European & Global Biomanufacturing
07 sept. 2022 04h43 HE | Research and Markets
Dublin, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The "19th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report has been added to ResearchAndMarkets.com's offering....
Monoclonal Antibodies (MAbS) Global Market Report 2022: Increasing Product Launches and Regulatory Support for the Treatment of Rare Diseases to Fuel Future Growth
31 août 2022 04h28 HE | Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies (MAbS) Global Market Report 2022: By Source, By Application, By End-User" report has been added to ResearchAndMarkets.com's...